HRP Anti-Integrin alpha 2 antibody [EPR17338] - C-terminal (ab209944)
Key features and details
- Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
- HRP Rabbit monoclonal [EPR17338] to Integrin alpha 2 - C-terminal
- Suitable for: IHC-P, WB
- Knockout validated
- Reacts with: Rat, Human
- Conjugation: HRP
Overview
-
Product name
HRP Anti-Integrin alpha 2 antibody [EPR17338] - C-terminal
See all Integrin alpha 2 primary antibodies -
Description
HRP Rabbit monoclonal [EPR17338] to Integrin alpha 2 - C-terminal -
Host species
Rabbit -
Conjugation
HRP -
Tested applications
Suitable for: IHC-P, WBmore details -
Species reactivity
Reacts with: Rat, Human
Predicted to work with: Mouse -
Immunogen
This information is proprietary to Abcam and/or its suppliers.
-
Positive control
- WB: A549, T-47D, C6 and wild-type HAP1 whole cell lysates and human fetal brain tissue lysates. IHC-P: Normal human colon tissue sections.
-
General notes
Alternative versions available:
Anti-Integrin alpha 2 antibody [EPR17338] - C-terminal (ab181548) - Knockout validatedThis product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties
-
Form
Liquid -
Storage instructions
Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle. Store In the Dark. -
Storage buffer
pH: 7.40
Preservative: 0.1% 10% Proclin 300 Solution
Constituents: 1% BSA, 30% Glycerol (glycerin, glycerine), PBS -
Concentration information loading...
-
Purity
Protein A purified -
Clonality
Monoclonal -
Clone number
EPR17338 -
Isotype
IgG -
Research areas
Images
-
IHC image of Integrin alpha 2 staining in a section of formalin-fixed paraffin-embedded normal human colon*, performed on a Leica BOND™. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab209944, 1/50 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
-
All lanes : HRP Anti-Integrin alpha 2 antibody [EPR17338] - C-terminal (ab209944) at 1/5000 dilution
Lane 1 : A549 (Human lung adenocarcinoma epithelial cell line) Whole Cell Lysate at 10 µg
Lane 2 : T-47D (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg
Lane 3 : C6 (Rat glioma cell line) Whole Cell Lysate at 10 µg
Lane 4 : Brain (Human) Tissue Lysate - fetal normal tissue at 10 µg
Lane 5 : Wild-type HAP1 cell lysate at 20 µg
Lane 6 : Integrin alpha 2 knockout HAP1 cell lysate at 20 µg
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 129 kDa
Observed band size: 170 kDa why is the actual band size different from the predicted?
Exposure time: 4 minutesThis blot was produced using a 3-8% Tris Acetate gel under the TA buffer system. The gel was run at 150V for 60 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab209944 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
-